Advertisement

Topics

Search Results for "Dcis Recurrence After Mastectomy"

20:27 EDT 30th March 2017 | BioPortfolio

Matching Channels

Tumor recurrence

Oncotrace

For optimal treatment in cancerology, clinicians need specific, precise, sensitive methods to quantify treatment response, monitor residual disease and detect early recurrence in patients. Residual ...

WolffParkinsonWhite WPW syndrome

Wolff–Parkinson–White syndrome (WPW) is a syndrome of pre-excitation of ventricles of the heart due to an accessory pathway known as the bundle of Kent. This accessory pathway is an abno...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Matching News

Radiation Boost Reduces Local Recurrence in DCIS Patients

A study presented last month at ASTRO found that a boost of radiation therapy following lumpectomy in DCIS patients resulted in reduced rates of local recurrence.

Local Recurrence Less Likely With Mastectomy in Younger Breast Cancer Patients

Over the long term, local recurrence is more likely in young women with invasive breast cancer who undergo breast conserving surgery compared with those who undergo mastectomy, though survival is no d...

High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case-control study

We aimed to evaluate the influence of mammographic breast density at diagnosis on the risk of cancer recurrence and survival outcomes in patients with invasive breast cancer after modified radical mas...

Surgical and social perspectives on nipple sparing mastectomy

Dr Galimberti speaks with ecancer at the 2017 St. Gallen International Breast Cancer ConferenceĀ about nipple sparing mastectomy, a surgical technique which aims to maintain the nipple and areola in r...

Jolie Effect: BRCA Tests Up but No Change in Mastectomy

After Angelina Jolie announced she had a double mastectomy because she carried BRCA gene mutations, rates of BRCA testing increased, but overall mastectomy rates did not change. Medscape Medical New...

Angelina Jolie’s mastectomy triggered sharp rise in gene testing

A 2013 announcement by the actor Angelina Jolie that she had had a mastectomy led to a sharp increase in breast cancer gene testing in US women but no change in overall mastectomy rates, a study in......

Tattoos Help Breast Cancer Patients Heal After Mastectomy

Artist David Allen empowers women who have had their breasts removed to feel a sense of control over their lives by drawing beautiful images over their mastectomy scars. Medscape Medical News

Burns in Reconstructed Breasts After Mastectomy

What are the most common causes of accidental burns to the breast after mastectomy with breast reconstruction -- and how can they be prevented? Wounds

Matching PubMed Articles

Controversies in the Treatment of Ductal Carcinoma in Situ.

Ductal carcinoma in situ (DCIS) accounts for 20% of all newly diagnosed breast cancers. Mastectomy was once the gold standard for the treatment of DCIS; however, breast-conserving surgery (BCS) has be...

Is Sentinel Lymph Node Dissection Necessary in All Patients with Ductal Carcinoma In Situ Undergoing Total Mastectomy?

When ductal carcinoma in situ (DCIS) is found on core needle biopsy, rates of upgrade to invasive cancer of 25 per cent and nodal positivity of 10 per cent have been reported. Sentinel lymph node diss...

The Relationships between HER2 Overexpression and DCIS Characteristics.

The aim of this study was to demonstrate the correlation between human epidermal growth factor receptor 2 (HER2) overexpression and some poor prognosis factors in patients affected by ductal carcinoma...

Benefit of low dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.

Low-dose tamoxifen has comparable antiproliferative effect to the standard dose of 20 mg/day in biomarker trials, but its clinical efficacy remains unclear. We assessed the effect of low-dose tamoxife...

Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery.

Local recurrence is a major concern in patients who have undergone surgery for ductal carcinoma in situ (DCIS). The present study assessed whether the expression levels of hormone receptors, human epi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement